RF vs SGMO
RF (RF) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
RF does not have a complete income-statement cache yet.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
RF currently screens at market cap $0. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the RF and SGMO stock pages for the full models.
Not investment advice.